MiNK Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure (NCT07615010) | MiNK Therapeutics | 2026-05-26 |
| A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors (NCT05108623) | MiNK Therapeutics | 2022-01-28 |
| agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma (NCT04754100) | MiNK Therapeutics | 2021-03-29 |
| A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS (NCT04582201) | MiNK Therapeutics | 2020-09-21 |
Track MiNK Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.